Home > Cashflow Statement > MANKIND PHARMA

MANKIND PHARMA
Cash Flow from Financing Activities

    Back to Cashflow Statement
MANKIND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Financing Activities ₹10,233 Cr₹5.27 Cr₹-740 Cr₹605 Cr₹-7.81 Cr

What is the latest Cash Flow from Financing Activities ratio of MANKIND PHARMA ?

The latest Cash Flow from Financing Activities ratio of MANKIND PHARMA is ₹10,233 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Financing Activities
Mar2025₹10,233 Cr
Mar2024₹5.27 Cr
Mar2023₹-740 Cr
Mar2022₹605 Cr
Mar2021₹-7.81 Cr

How is Cash Flow from Financing Activities of MANKIND PHARMA Trending?

Years Cash Flow from Financing Activities % Change
Mar2025 ₹10,233 Cr
194,066.22
Mar2024 ₹5.27 Cr
Positive
Mar2023 ₹-740 Cr
Negative
Mar2022 ₹605 Cr
Positive
Mar2021 ₹-7.81 Cr -

Compare Cash Flow from Financing Activities of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹104,780.2 Cr 7.7% 0.9% 2.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹447,104.0 Cr 3.5% -1.5% 9% Stock Analytics
DIVIS LABORATORIES ₹180,119.0 Cr 1.1% -1.1% 0.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹150,871.0 Cr -0.2% -0.3% 35% Stock Analytics
CIPLA ₹114,334.0 Cr 3.1% 1% -11.3% Stock Analytics
DR REDDYS LABORATORIES ₹107,761.0 Cr 1.1% -2.1% -5.6% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

7.7%

0.9%

2.1%

SENSEX

1.1%

2.4%

-5%


You may also like the below Video Courses